Speaker: Andrea Monti Hughes, PhD

Background: Andrea is a senior researcher at the National Atomic Energy Commission and the National Research Council of Argentina. She is devoted to the study of the radiobiology of Boron Neutron Capture Therapy (BNCT), a selective particle therapy that combines the administration of boron compounds that accumulate preferentially in tumor tissue with a thermal neutron irradiation.

Her main interests are the study of BNCT for the treatment of oral cancer and precancer. With national and international collaborations, she evaluates new boron compounds and strategies to optimize BNCT therapeutic efficacy and to reduce BNCT-induced toxicity. She also coordinated BNCT clinical-veterinary studies in dogs with head and neck cancer with no other treatment option. She is a member of the Board of Councillors, the Communication task force and the Radiobiology working group of the ISNCT (International Society of Neutron Capture Therapy, https://isnct.net/) and of the PTCOG (Particle Cooperative Group) BNCT Working group.

Click here to view Andrea's paper published in Expert Reviews in Molecular Medicine.

Click here to watch the webinar.

Speaker: Andrea Monti Hughes, PhD

Background: Andrea is a senior researcher at the National Atomic Energy Commission and the National Research Council of Argentina. She is devoted to the study of the radiobiology of Boron Neutron Capture Therapy (BNCT), a selective particle therapy that combines the administration of boron compounds that accumulate preferentially in tumor tissue with a thermal neutron irradiation.

Her main interests are the study of BNCT for the treatment of oral cancer and precancer. With national and international collaborations, she evaluates new boron compounds and strategies to optimize BNCT therapeutic efficacy and to reduce BNCT-induced toxicity. She also coordinated BNCT clinical-veterinary studies in dogs with head and neck cancer with no other treatment option. She is a member of the Board of Councillors, the Communication task force and the Radiobiology working group of the ISNCT (International Society of Neutron Capture Therapy, https://isnct.net/) and of the PTCOG (Particle Cooperative Group) BNCT Working group.

Click here to view Andrea's paper published in Expert Reviews in Molecular Medicine.

Click here to watch the webinar.

Speaker: Andrea Monti Hughes, PhD

Background: Andrea is a senior researcher at the National Atomic Energy Commission and the National Research Council of Argentina. She is devoted to the study of the radiobiology of Boron Neutron Capture Therapy (BNCT), a selective particle therapy that combines the administration of boron compounds that accumulate preferentially in tumor tissue with a thermal neutron irradiation.

Her main interests are the study of BNCT for the treatment of oral cancer and precancer. With national and international collaborations, she evaluates new boron compounds and strategies to optimize BNCT therapeutic efficacy and to reduce BNCT-induced toxicity. She also coordinated BNCT clinical-veterinary studies in dogs with head and neck cancer with no other treatment option. She is a member of the Board of Councillors, the Communication task force and the Radiobiology working group of the ISNCT (International Society of Neutron Capture Therapy, https://isnct.net/) and of the PTCOG (Particle Cooperative Group) BNCT Working group.

Click here to view Andrea's paper published in Expert Reviews in Molecular Medicine.

Click here to watch the webinar.